2022 Speakers

Anwesha Dey

Principal Scientist, Discovery Oncology

Genentech

Giorgio Galli

Associate Director

Novartis

Len Post

Chief Scientific Officer

Vivace Therapeutics

WanJin Hong

Professor & Executive Director, Institute of Molecular and Cell Biology

A*STAR

Jason Faris, Novartis

Jason Faris

Senior Clinical Program Leader

Novartis Institutes for BioMedical Research

Kieran Harvey

Group Leader

Peter MacCallum Cancer Centre & Monash University

Wolf Ruprecht Wiedemeyer

Biology Director

BridGene Biosciences

Xu Wu

Associate Professor

Massachusetts General Hospital, Harvard Medical School

Jeffrey Ecsedy

Chief Development Officer

Ikena Oncology

Kun-Liang Guan

Distinguished Professor Department of Pharmacology

University of California San Diego

Sophia Shalhout

Cutaneous Oncology Research Fellow, Mass General Cancer Center

Harvard Medical School

Stephen Gwaltney

Head of Drug Discovery

SpringWorks Therapeutics

Irena Konstantinova

Head of Biology

Inventiva Pharma

Iris Valtingojer

Group Leader, Oncology Research

Sanofi R&D

Stéphanie Guéret

Associate Principal Scientist

AstraZeneca

Brian Rubin

Chair, Pathology & Laboratory Medicine

The Cleveland Clinic

Michelle Zhang

Chief Scientific Officer

Ikena Oncology

Olivier Venier

Group Leader, Medicinal Chemistry, Integrated Drug Discovery

Sanofi

Timo Heinrich

Associate Scientific Director, Head of Laboratory

Merck Healthcare KGaA